Bio-Path Holdings (BPTH) Misses Q4 EPS by 144c

Bio-Path Holdings (NASDAQ: BPTH) reported Q4 EPS of ($1.91), $1.44 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FuelCell Energy signs deal with Fit Energy for up to 380 MW of power
• KB Home (KBH) PT Raised to $66 at UBS on Market Stabilisation and Execution